Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors
- 1 April 2019
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 168, 87-109
Abstract
No abstract availableKeywords
Funding Information
- MICINN (ADE08/90038)
This publication has 57 references indexed in Scilit:
- Abnormal hematopoietic phenotypes in Pim kinase triple knockout miceJournal of Hematology & Oncology, 2013
- A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseLeukemia Research, 2012
- Pim Kinase Inhibitors Sensitize Prostate Cancer Cells to Apoptosis Triggered by Bcl-2 Family Inhibitor ABT-737Cancer Research, 2012
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cellsOncogene, 2011
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancersHaematologica, 2010
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cellsBlood, 2009
- Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanesMolecular Cancer Therapeutics, 2009
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenesBlood, 2008
- H++: a server for estimating pKas and adding missing hydrogens to macromoleculesNucleic Acids Research, 2005